(Q48607482)

13 February 2018

title

Neuro-oncology: Glioblastoma--community adjusts to new standard of care (English)

1 reference

13 February 2018

2

Henry S Friedman

1 reference

13 February 2018

1

Annick Desjardins

1 reference

13 February 2018

language of work or name

English

0 references

publication date

20 March 2012

1 reference

13 February 2018

published in

Nature Reviews Neurology

1 reference

13 February 2018

volume

8

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

page(s)

244-246

1 reference

13 February 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.42

Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.42

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.42

Glioma extent of resection and its impact on patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.42

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.42

Recent developments in the use of chemotherapy in brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.42

Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.42

Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.42

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.42

21 January 2018

Identifiers

DOI

10.1038/NRNEUROL.2012.42

1 reference

13 February 2018

1 reference

13 February 2018